Latest News

Food and non-food allergies are often associated with childhood, but millions of adults across the UK live with allergies too. Around 6% of the UK adult population has a clinically confirmed food…

Following the Government’s announcement earlier this year of new allergy guidance to help keep children safe in schools, the Department for Education has now published its statutory guidance. The new requirements will…

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a lower-dose version of the adrenaline nasal spray, EURneffy®, for the emergency treatment of serious allergic reactions (anaphylaxis) in children aged four…

The announcement that Natasha’s Foundation has launched Natasha’s Prize – a groundbreaking £10 million fund dedicated to research into preventing allergies – has been hugely encouraging for the allergy community.  As a charity supporting…

The National Institute for Health and Care Excellence (NICE) has published updated guidance on the assessment and referral of people following emergency treatment for anaphylaxis. This new guideline replaces NICE guideline CG134…

Anaphylaxis UK and Allergy UK to merge, creating a stronger, unified voice for people living with allergy and anaphylaxis.  Anaphylaxis UK and Allergy UK today announce their intention to merge on the 1st of October, bringing…

A new international review has highlighted important inequalities in the prevalence, management, and outcomes of IgE-mediated food allergies among children from different ethnic backgrounds. The scoping review, published in the World Allergy…

New research from the University of Bristol and Bristol Royal Hospital for Children has highlighted critical delays in the use of adrenaline auto-injectors (AAIs) in children experiencing fatal food-induced anaphylaxis, prompting calls for urgent…

If you’re at the Allergy & Free From Show on 9-10 May at NEC Birmingham, come and say hello to our team of staff and volunteers with lived experience of allergies on…